📌 Key Takeaways
- Topic: Silica Market Trends 2026: Demand Drivers, Technologies and Regional Outlook
- Keywords: silica for skincare
- Published: 2026-11-20 07:45:53
- Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
Crystalline Silica Dust Hazard: Health Risks and How to Protect Workers
- What Is Synthetic Amorphous Silica (SAS)? Types, Safety and Regulatory Status
- Cheng, C.-A., Deng, T., Lin, F.-C., Cai, Y. & Zink, J. I. Supramolecular nanomachines as stimuli-responsive gatekeepers on mesoporous silica nanoparticles for antibiotic and cancer drug delivery. Theranostics 9, 3341 (2019). Article CAS PubMed Central PubMed Google Scholar
- Crystalline Silica Powder: Grades, Uses and Safe Handling Requirements
- Barenholz, Y. C. Doxil - The first FDA-approved nano-drug: Lessons learned. J. Control. Release 160, 117-134 (2012). Article CAS PubMed Google Scholar
- Silica Distributor vs Manufacturer: Which Is Better for Your Purchase?
- Zhang, F. et al. Coordination and redox dual‐responsive mesoporous organosilica nanoparticles amplify immunogenic cell death for cancer chemoimmunotherapy. Small 17, 2100006 (2021). Post CAS Google Scholar
- Admatechs Silica: Submicron Spherical Silica Products and Applications
Chinese Fumed Silica vs Aerosil: Quality, Performance and Price Compared
What is silica (SiO₂)?
Nouryon Levasil
What is the difference between fumed silica and precipitated silica?
fumed silica alternative Targeted delivery tactics are generally divided into two categories: passive targeting and active targeting. Passive targeting relies on the pathological qualities of the disease microenvironment and the nature of the drug delivery system itself, which allows the drug to effectively accumulate at the lesion site of disease. The most well-known passive targeting is the EPR effect of tumor, which refers to the phenomenon that some particles with particular size (20-200 nm) penetrate more without difficulty into tumor tissue and remain there for a long time when compared to normal tissue. 316, 317 Therefore, controlling the size of MSNs to a fitting range will facilitate their enrichment in the tumor sites. However, it has also been highlighted that the passive targeting strategy relying on the EPR effect can attain only 0.7% of the injected NPs enrichment in solid tumors, 318 which will not be handy for the clinical translation of nanotechnology. In contrast, active targeting relies on the active recognition between the molecules on the NPs surface and the specific molecules or proteins in the illness microenvironment, which is also referred to as ligand-receptor specific binding. 319 The active targeting shows a higher drug delivery efficiency compared to passive targeting. 320 Targeted ligands, such as proteins, antibodies, peptides, nucleic acids and chemical tiny molecules, can be modified on the surface of MSNs, and the modified MSNs are capable of selectively aggregating at the lesion site based on the powerful affinity between the targeted ligands and the particular receptors overexpressed in the sickness microenvironment. 321, 322, 323, 324 For instance, compared to mature vascular endothelial cells, tumor neovascular endothelial cells are highly expressed in an array of proteins, such as integrins, transmembrane glycoproteins and aminopeptidase N. Molecules that recognize these highly expressed proteins can be used for neovascular-based targeted drug delivery. A standard example is that arginylglycylaspartic acid (RGD)-modified MSNs can selectively bind integrin α ν β 3 receptor and hence be applied to target tumor neovascularization. 325
What drives silica raw material prices?
Wacker HDK The complexity and heterogeneity of the illness microenvironment brings about the problem of poor therapeutic efficiency of single therapies. 465, 466, 467, 468, 469 The current clinical research trend has steadily shifted to multimodal synergistic therapy, as we have noted above with many examples of multimodal synergistic therapy platform construction. In multimodal synergistic therapy, the interaction between different treatment modalities can substantially boost the shortcomings of single therapy, such as overcoming the lack of light penetration depth in PDT, lowering the toxic side effects of chemotherapy, etc., and producing stronger therapeutic outcome through superimposed impacts (namely "1 + 1 > 2"). 470, 471, 472 A prominent feature of multimodal synergistic therapies is the skill to effectively overcome multidrug resistance in diseases, and MSNs are uniquely advantageous in integrating these aforementioned treatment modalities. 369, 473, 474, 475 As an illustration, most of the multidrug resistance generated during chemotherapy of malignant tumors might stem from the overexpression of transmembrane ATP-binding cassette transporter and transmembrane Ca 2+ channels. 476, 477 To address this problem, researchers used mesoporous silica nanocapsules to encapsulate and deliver the cytotoxic drug DOX and T-type Ca 2+ channel siRNA. 478 On the one hand, MSNs can bypass the drug efflux pumps and enter cells directly through endocytosis, increasing the intracellular accumulation of drugs. On the other hand, siRNA can knock down the T-type Ca 2+ channel, leading to a decrease in cytosol Ca 2+ concentration in the cytosol, thus increasing the sensitivity of tumor cells to DOX. Accordingly, the as-designed MSNs-based therapeutic system attained effective chemotherapy-gene therapy to overcome the multidrug resistance in breast cancer. 478 Besides, drug-resistant bacterial infections are a current thorny public health issue. 479 In this regard, researchers have developed a photodynamic combined lysozyme antimicrobial therapy based on upconversion NPs/MSNs nanocomposites to combat the problem of drug-resistant bacterial infections in deep tissues. Briefly, upconversion NPs were sequentially encapsulated with hierarchical coating of dense silica and dendritic mesoporous silica, followed by loading photosensitizers and lysozyme, and finally modified with bacterial hyaluronidase-response valves on the MSNs surface to accomplish controllable release of lysozyme. The results demonstrated that this system promoted direct attack of ROS on cell membranes and cytoplasm through enzymatic cell wall disassembly, resulting in an excellent bactericidal rate toward methicillin-resistant Staphylococcus aureus (> 5 log10 viability reduction). 480
/news/article.htmlDisclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.